| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8273048 | Journal of the Neurological Sciences | 2018 | 6 Pages |
Abstract
The patients' clinical courses suggest that anti-NF155 antibody levels and NCS findings could be disease activity markers in anti-NF155 antibody-positive CIDP.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Atsushi Fujita, Hidenori Ogata, Ryo Yamasaki, Takuya Matsushita, Jun-ichi Kira,